2017 Autism CARES Meeting Evaluation

1.

Thank you for attending the 2017 Autism CARES Meeting, Pathways to Progress: Overcoming Barriers to Access, Translating Research to Practice, and Reducing Health Disparities. Your attendance and active participation were greatly appreciated.

Please take a few minutes to complete the following survey questions regarding the 2017 Meeting. Your responses are very important and will be used as the planning committee moves forward for future CARES grantee activities.

Question Title

* 1. Please provide the type of program(s) with which you are affiliated. You may select more than one.

Research Networks: AIR-B, AIR-P, DBPNet, Healthy Weight, Transition

Other Research Grantees

State Implementation Grants

LEND

DBP

Federal Agency Representative

TA Provider

Other

Other (please specify):

Question Title

* 2. Overall, how satisfied were you with the 2017 Autism CARES Meeting?

Very satisfied

Satisfied

Dissatisfied

Very dissatisfied

Comments:

Question Title

* 3. How likely are you to incorporate something you learned from the 2017 Autism CARES Meeting into your work?

Very likely

Likely

Somewhat likely

Not very likely

Comments:

Question Title

* 4. The following sessions increased my knowledge or awareness of information that is useful to me in my work:

	Strongly agree	Agree	Disagree	Strongly disagree
Monday's CARES Evaluation Presentation	Monday's CARES Evaluation Presentation Strongly agree	Monday's CARES Evaluation Presentation Agree	Monday's CARES Evaluation Presentation Disagree	Monday's CARES Evaluation Presentation Strongly disagree
Monday's Grantee Mini-Keynotes	Monday's Grantee Mini-Keynotes Strongly agree	Monday's Grantee Mini-Keynotes Agree	Monday's Grantee Mini-Keynotes Disagree	Monday's Grantee Mini-Keynotes Strongly disagree
Monday's Concurrent Sessions	Monday's Concurrent Sessions Strongly agree	Monday's Concurrent Sessions Agree	Monday's Concurrent Sessions Disagree	Monday's Concurrent Sessions Strongly disagree
"Moving Forward Together" Concurrent Sessions	"Moving Forward Together" Concurrent Sessions Strongly agree	"Moving Forward Together" Concurrent Sessions Agree	"Moving Forward Together" Concurrent Sessions Disagree	"Moving Forward Together" Concurrent Sessions Strongly disagree
Tuesday's Transition Report to Congress	Tuesday's Transition Report to Congress Strongly agree	Tuesday's Transition Report to Congress Agree	Tuesday's Transition Report to Congress Disagree	Tuesday's Transition Report to Congress Strongly disagree
Tuesday's "Working Together" Partnership Panel	Tuesday's "Working Together" Partnership Panel Strongly agree	Tuesday's "Working Together" Partnership Panel Agree	Tuesday's "Working Together" Partnership Panel Disagree	Tuesday's "Working Together" Partnership Panel Strongly disagree
Tuesday's Policy Update	Tuesday's Policy Update Strongly agree	Tuesday's Policy Update Agree	Tuesday's Policy Update Disagree	Tuesday's Policy Update Strongly disagree
Tuesday's Grantee Poster Symposium	Tuesday's Grantee Poster Symposium Strongly agree	Tuesday's Grantee Poster Symposium Agree	Tuesday's Grantee Poster Symposium Disagree	Tuesday's Grantee Poster Symposium Strongly disagree
Small Group Discussions	Small Group Discussions Strongly agree	Small Group Discussions Agree	Small Group Discussions Disagree	Small Group Discussions Strongly disagree
Tuesday's Closing Keynote	Tuesday's Closing Keynote Strongly agree	Tuesday's Closing Keynote Agree	Tuesday's Closing Keynote Disagree	Tuesday's Closing Keynote Strongly disagree

Comments:

Question Title

* 5. The 2017 Autism CARES Meeting allowed me to network and develop new collaborations.

Strongly agree

Agree

Disagree

Strongly disagree

Comments:

Question Title

* 6. Please briefly indicate what you found to be the most valuable aspect(s) of the 2017 CARES Meeting:

Question Title

* 7. Please briefly indicate what aspect(s) of the 2017 CARES Meeting you would want changed for future meetings:

Question Title

* 8. The format of this meeting (plenary panels, small group discussions, poster symposia) met my needs for learning.

Strongly agree

Agree

Disagree

Strongly disagree

Comments:

Question Title

* 9. The meeting facilities and location worked well for the event.

Strongly agree

Agree

Disagree

Strongly disagree

Comments:

Innovation Station Evaluation

For questions or more information contact Lynda Krisowaty at lkrisowaty@amchp.org or 202-266-3058

Question Title

* 10. Which resource is most useful to you in considering whether or not to submit a practice to Innovation Station?

Information provided in the email reminder

Submission form and one pager in the participant packet

Briefly discussing Innovation Station during the poster session discussion

AMCHP table with Innovation Station resources

Other (please explain):

Question Title

* 1. Please provide the type of program(s) with which you are affiliated. You may select more than one.

Question Title

* 2. Overall, how satisfied were you with the 2017 Autism CARES Meeting?

Question Title

* 3. How likely are you to incorporate something you learned from the 2017 Autism CARES Meeting into your work?

Question Title

* 4. The following sessions increased my knowledge or awareness of information that is useful to me in my work:

Question Title

* 5. The 2017 Autism CARES Meeting allowed me to network and develop new collaborations.

Question Title

* 6. Please briefly indicate what you found to be the most valuable aspect(s) of the 2017 CARES Meeting:

Question Title

* 7. Please briefly indicate what aspect(s) of the 2017 CARES Meeting you would want changed for future meetings:

Question Title

* 8. The format of this meeting (plenary panels, small group discussions, poster symposia) met my needs for learning.

Question Title

* 9. The meeting facilities and location worked well for the event.

Question Title

* 10. Which resource is most useful to you in considering whether or not to submit a practice to Innovation Station?

Question Title

* 11. What can AMCHP do to make it easier for you to submit a practice to Innovation Station?